Searched over 200M research papers
10 papers analyzed
These studies suggest cardiovascular disease (CVD) is a broad term for disorders of the heart and blood vessels, including ischemic heart disease, stroke, heart failure, and peripheral arterial disease, and is influenced by various risk factors and molecular mechanisms.
20 papers analyzed
Cardiovascular disease (CVD) refers to a broad category of disorders affecting the heart and blood vessels. These include ischemic heart disease, stroke, heart failure, peripheral arterial disease, hypertension, coronary artery disease (CAD), cardiac dysrhythmias, cerebrovascular disease, valvular heart disease, cardiomyopathies, and congenital cardiac abnormalities . CVDs are the leading cause of global mortality, contributing significantly to premature death and disability .
The primary underlying cause of many CVDs is atherosclerosis, a condition characterized by the buildup of fatty deposits in the arterial walls, leading to narrowed and hardened arteries . This process can result in coronary artery disease, cerebrovascular disease, and peripheral vascular disease, which may subsequently cause myocardial infarction, cardiac arrhythmias, or stroke. Key mechanisms involved in the development of atherosclerosis include endothelial dysfunction, inflammation, and oxidative stress.
Several well-recognized risk factors contribute to the onset and progression of CVDs. These include:
In addition to these traditional risk factors, non-traditional factors such as chronic volume overload, anemia, inflammation, oxidative stress, and chronic kidney disease–mineral bone disorder also play a significant role, particularly in specific populations like dialysis patients.
CVDs are the leading cause of death worldwide, creating a substantial socio-economic burden due to the high costs of healthcare and loss of productivity . The incidence and prevalence of CVDs vary widely by country and culture, with certain populations, such as South Asian migrants, experiencing a higher burden of coronary artery disease due to factors like increased abdominal obesity, type 2 diabetes, and dyslipidemia .
Primary prevention and treatment strategies for CVDs focus on managing the underlying risk factors. These include:
Despite the effectiveness of these treatments, significant gaps remain in the management of CVDs, necessitating ongoing research and development of new therapeutic strategies.
Recent advances in molecular biology and genetics have provided new insights into the pathophysiology of CVDs. For instance, disparities in the expression of genes and microRNAs (miRNAs) play crucial roles in the development and progression of CVDs, making them potential diagnostic biomarkers and therapeutic targets. Additionally, the use of induced pluripotent stem cells (iPSCs) has revolutionized the study of CVDs, offering unprecedented opportunities to investigate disease mechanisms at the cellular level and develop new treatments .
Cardiovascular disease encompasses a wide range of heart and blood vessel disorders that are the leading cause of global mortality. Understanding the pathophysiology, risk factors, and current treatment strategies is crucial for managing and preventing these life-threatening conditions. Ongoing research and advancements in molecular biology and genetics hold promise for improving our understanding and treatment of CVDs, ultimately reducing their global burden.
Most relevant research papers on this topic